Skip to main content

Table 3 Means and SDs of OCD, anxiety and depressive scores before and after rTMS treatment based on the response (responders vs nonresponders) and protocol (SMA rTMS vs DLPFC rTMS)

From: Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study

Measure

Response

pre-intervention

post-intervention

Pre vs post

M (SD)

t (sig)

M (SD)

t (sig)

t (sig)

Y-BOCS

responders

22.90 (6.94)

−0.32 (0.75)

12.73 (6.01)

−5.38 (0.01)

12.39 (0.001)

non-responders

22.62 (6.50)

21.02 (5.97)

2.35 (0.025)

total

22.75 (6.66)

 

17.20 (7.25)

 

7.43 (0.001)

SMA rTMS

23.52 (7.37)

1.11 (0.27)

18.13 (7.95)

1.23 (0.22)

3.06 (0.003)

DLPFC rTMS

21.66 (5.44)

15.88 (6.04)

3.69 (0.001)

BAI

responders

27.00 (9.72)

0.60 (0.54)

15.13 (7.51)

−0.71 (0.47)

5.84 (0.001)

non-responders

24.97 (12.06)

18.37 (10.65)

2.95 (0.005)

total

25.91 (11.01)

 

16.87 (9.41)

 

5.83 (0.001)

SMA rTMS

24.71 (10.15)

−1.04 (0.30)

16.94 (9.95)

0.07 (0.94)

3.36 (0.001)

DLPFC rTMS

27.59 (12.10)

16.77 (8.77)

3.76 (0.001)

BDI-II

responders

22.50 (9.78)

−0.20 (0.84)

16.43 (9.93)

−0.12 (0.91)

3.17 (0.003)

non-responders

22.77 (8.32)

17.28 (9.16)

3.25 (0.002)

total

22.64 (8.95)

 

16.89 (9.46)

 

4.57 (0.001)

SMA rTMS

21.84 (9.86)

−0.85 (0.39)

16.07 (9.28)

−82 (0.41)

2.62 (0.010)

DLPFC rTMS

23.77 (7.54)

18.03 (9.77)

2.42 (0.019)

  1. Y-BOCS Yale-Brown Obsessive-Compulsive Scale, BAI Beck Anxiety Inventory, BDI-II Beck Depression Inventory, M Mean, SD Standard Deviation. Significant results are highlighted (p ≤ 0.05) in bold